What is Global Medical Bioactive Glass Market?
The Global Medical Bioactive Glass Market is a specialized sector within the broader medical industry that focuses on the production and application of bioactive glass. Bioactive glass is a type of glass that, when used in the body, elicits a specific biological response at the interface of the material which results in the formation of a bond between the tissues and the glass. This unique property makes it an ideal material for various medical applications, particularly in the fields of orthopedics and dentistry. The market for this product is global in nature, with demand stemming from healthcare providers, research institutions, and patients all over the world. The market is driven by the increasing prevalence of diseases and conditions that require the use of bioactive glass, such as bone fractures, dental decay, and cosmetic surgeries. However, the market's growth is also influenced by factors such as technological advancements in the production of bioactive glass, regulatory policies, and the level of awareness among potential users.
45S5, S53P4, Others in the Global Medical Bioactive Glass Market:
The Global Medical Bioactive Glass Market is segmented based on the type of bioactive glass, namely 45S5, S53P4, and others. 45S5 is a type of bioactive glass that is composed of silicon dioxide, calcium oxide, sodium oxide, and phosphorus pentoxide. It is the most commonly used type of bioactive glass due to its proven biocompatibility and ability to bond with both hard and soft tissues. S53P4, on the other hand, is a type of bioactive glass that is composed of silicon dioxide, sodium oxide, calcium oxide, and phosphorus pentoxide. It is primarily used in the treatment of chronic bone infections due to its antimicrobial properties. The "others" category includes various other types of bioactive glass that are used in specific applications. The choice of bioactive glass depends on the specific medical application, the patient's condition, and the healthcare provider's preference.
Bone Materials, Dental Materials, Cosmetics in the Global Medical Bioactive Glass Market:
The Global Medical Bioactive Glass Market finds its application in various areas such as bone materials, dental materials, and cosmetics. In the field of bone materials, bioactive glass is used in the treatment of bone fractures and defects. It is used as a graft material in bone surgeries due to its ability to stimulate bone regeneration and form a strong bond with the surrounding bone tissue. In the field of dental materials, bioactive glass is used in the treatment of dental decay and periodontal diseases. It is used in the production of dental fillings, root canal sealers, and periodontal products due to its ability to remineralize tooth enamel and inhibit bacterial growth. In the field of cosmetics, bioactive glass is used in the production of skin care products. It is used due to its ability to stimulate skin regeneration and improve skin health.
Global Medical Bioactive Glass Market Outlook:
The Global Medical Bioactive Glass Market is projected to grow at a steady pace in the coming years. As of 2022, the market was valued at US$ 405.2 million and it is expected to reach US$ 562.5 million by 2029, growing at a compound annual growth rate (CAGR) of 4.6% during the forecast period of 2023-2029. The largest market for medical bioactive glass is North America, which accounts for about 60% of the global market share. This is followed by Europe, which holds about 35% of the market share. The largest segment of the market is bone materials, which accounts for about 57% of the market share. This is followed by dental materials, which hold about 22% of the market share. The growth of the market is driven by the increasing prevalence of diseases and conditions that require the use of bioactive glass, technological advancements in the production of bioactive glass, and the increasing awareness among potential users.
| Report Metric | Details |
| Report Name | Medical Bioactive Glass Market |
| Accounted market size in 2022 | US$ 405.2 million |
| Forecasted market size in 2029 | US$ 562.5 million |
| CAGR | 4.6% |
| Base Year | 2022 |
| Forecasted years | 2023 - 2029 |
| Segment by Type |
|
| Segment by Application |
|
| Consumption by Region |
|
| By Company | Zimmer Biomet Holdings, Inc., Stryker, SCHOTT, BonAlive Biomaterials, NovaBone, Beijing Xinfuyisheng High Technology, Prosidyan, Ferro, Mo-Sci Corporation, Synergy Biomedical, 3M, Matexcel, Noraker, Ugulin, Kunshan Overseas Chinese Technology New Materials, Zhangjiagang Lanzhi Biotechnology, Guangzhou Kejin Material Technology |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
